Clinical Trials Directory

Trials / Unknown

UnknownNCT05005494

Hypnotic and Anti-nociceptive Components of Magnesium

Study of the Hypnotic and Anti-nociceptive Components of Magnesium Using Electroencephalogram Spectral Entropy and Pupillometry During Total Intravenous General Anaesthesia

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Liege · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of our study is to evaluate the effect of magnesium on the hypnotic effect of propofol.

Detailed description

The aim of our study is to evaluate the effect of magnesium on the hypnotic effect of propofol. To achieve this, the investigators will analyse the effect of magnesium on the brain concentrations of propofol required to achieve a State Entropy value between 50-60, which corresponds to the recommended depth of anaesthesia. Our study will also evaluate the intraoperative anti- nociceptive effect of magnesium using pupillometry and its two indices, PPI and PRD

Conditions

Interventions

TypeNameDescription
DRUGMagnesium sulfate IVInfusion of magnesium sulphate 50 mg/kg (eq. 0.5ml/kg of magnesium sulphate 100mg/ml)
DRUGPlaceboInfusion of NaCl (sodium chloride) 0.9% (placebo eq. 0.5ml/kg of NaCl 0.9%)

Timeline

Start date
2021-09-01
Primary completion
2021-11-01
Completion
2021-12-01
First posted
2021-08-13
Last updated
2021-08-19

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05005494. Inclusion in this directory is not an endorsement.